Frazier Life Sciences Management, L.P. An2 Therapeutics, Inc. Transaction History

Frazier Life Sciences Management, L.P.

  • $1.9 Billion
  • Q2 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$1.93 - $3.76 $1.35 Million - $2.63 Million
700,000 Added 50.4%
2,088,889 $4.49 Million
Q3 2023

Nov 14, 2023
BUY
$7.58 - $16.08 $10.5 Million - $22.3 Million
1,388,889 New
1,388,889 $22.3 Million

Others Institutions Holding ANTX

# of Institutions
38
Shares Held
7.58M
Call Options Held
0
Put Options Held
0
View Full List

About AN2 Therapeutics, Inc.

ANTX Quotes by TradingView
  • Ticker ANTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,402,700
  • Market Cap $24.8M
  • Description
  • AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...
More about ANTX
Track This Portfolio

Track Frazier Life Sciences Management, L.P. Portfolio

Follow Frazier Life Sciences Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Life Sciences Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Frazier Life Sciences Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email